How Long Is Bacteriostatic Water Good For After Opening?
Handling and storage
How long is bacteriostatic water good for after you open it? The short answer is about 28 days from the first time you puncture the stopper — a beyond-use date set by USP standards and echoed by the CDC. Here is where that number comes from, what makes bacteriostatic water different from plain sterile water, and how to handle an opened vial so the 28 days actually mean something.
How long is bacteriostatic water good for after opening?
For a multi-dose vial of bacteriostatic water, the widely used rule is to discard it within 28 days of first entry. The clock does not start when you buy it or when the box says it expires — it starts the moment a needle first pierces the rubber stopper. From that point you have roughly four weeks, and never past the manufacturer’s printed expiration date, whichever comes first.
Write the puncture date on the vial. That one habit is what turns “28 days” from a guideline into something you can actually follow.
What bacteriostatic water actually is
Bacteriostatic water for injection is sterile water with a preservative added — benzyl alcohol, typically at 0.9% (9 mg/mL), though some products use 1.1%. That preservative is bacteriostatic, meaning it limits the growth of bacteria between withdrawals. It does not sterilize the vial, and it has no effect on viruses. That is exactly why a time limit exists: the preservative buys you repeated safe entries, not indefinite ones.
This is the core difference from sterile water for injection, which has no preservative at all. No preservative means no 28-day window — a single-use vial is meant to be used once and discarded.
Where the 28-day rule comes from
The number traces to USP General Chapter <797>, the compounding standard for sterile preparations, and it is quoted directly by the CDC’s injection-safety guidance. The rule, in plain terms: an unopened multi-dose vial follows the manufacturer’s expiration date; once opened or punctured, it should be dated and discarded within 28 days, unless the manufacturer specifies a different (shorter) date, and never beyond the original printed expiration.
The one hard limit: not for newborns
The preservative that makes bacteriostatic water convenient is also its main safety caveat. Benzyl alcohol is not for use in neonates — it has been linked to serious toxicity in newborns (historically described in the medical literature as “gasping syndrome”). Product labeling states that where water is needed for newborns, only preservative-free sterile water for injection should be used. Labels also note that bacteriostatic water is not intended for fluid replacement and not for epidural or spinal procedures. These are documented, verifiable contraindications worth respecting.
Handling an opened vial safely
To make the full 28 days count, a few simple, label-supported habits do the heavy lifting:
- Date it at first puncture, so the 28-day clock is visible.
- Swab the stopper with alcohol before every entry — standard aseptic technique.
- Inspect before each use: the solution should be clear and the seal intact.
- Discard early if it turns cloudy, discolored, or shows any particles.
- Store at room temperature (about 20 to 25 C for the common product) — but always follow your specific vial’s label.
- Stop at 28 days, or sooner if the label says so.
For related measurement steps, our reconstitution calculator and the guide on how much BAC water to add for a target concentration cover the math side.
Why single-use sterile water has no 28-day window
Single-dose and preservative-free products are a different story. Without an antimicrobial preservative, there is nothing to limit bacterial growth once the vial is opened, so the safe move is to use it and discard it — not save leftovers for later. The 28-day allowance is a property of the preserved, multi-dose format, not of “water” in general.
Frequently asked questions
Does bacteriostatic water need to be refrigerated after opening?
The common product is labeled for storage at room temperature (about 20 to 25 C), so refrigeration is generally not required — but follow the specific label on your vial, since products can differ.
What if I only used it once — is it still good for 28 days?
The 28-day limit is counted from the first puncture regardless of how many times you have drawn from it. One entry still starts the clock, because the stopper’s sterility is what the window protects.
Can I use it past 28 days if it still looks clear?
Looking clear is necessary but not sufficient. The 28-day beyond-use date is a conservative infection-control convention; a preservative limits, but does not eliminate, contamination risk. The standard guidance is to discard at 28 days.
Is bacteriostatic water the same as sterile water?
No. Both are sterile at the start, but bacteriostatic water contains benzyl alcohol as a preservative and is multi-dose, while sterile water for injection is preservative-free and single-use.
- CDC. Preventing Unsafe Injection Practices (multi-dose vial and 28-day guidance). cdc.gov
- DailyMed. Bacteriostatic Water for Injection, USP (Hospira) label. dailymed.nlm.nih.gov
- USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations. usp.org
- USP. General Chapter <797> FAQs (beyond-use dating). go.usp.org
- Drugs.com. Bacteriostatic Water for Injection prescribing information. drugs.com
- DailyMed. Bacteriostatic Water for Injection (alternate label). dailymed.nlm.nih.gov
Informational only — not medical advice. For research and educational use by adults 21+. Always follow the specific product label and consult a qualified professional.
In Plain English
BPC-157 is a lab-made copy of a small piece of a protein found naturally in the stomach. In animal studies it appears to help injured tissue — like muscle, tendon, and the gut lining — heal faster. Researchers are interested in it as a possible all-purpose recovery aid, but almost all of the evidence so far comes from animals rather than people.
BPC-157 (Body Protection Compound-157) is a synthetic chain of 15 amino acids based on a sequence found in human gastric juice. First described by a research group in Zagreb in the early 1990s, it has become one of the most-studied “healing” peptides in preclinical science. This profile summarizes what BPC-157 is, how researchers describe its activity, and what the published literature actually shows — for informational purposes only.
What is BPC-157?
BPC-157 is a stable gastric pentadecapeptide — “pentadecapeptide” simply means a peptide of fifteen amino acids. It is a partial sequence derived from a larger body-protection compound isolated from gastric juice, and it is notably stable in human gastric acid, which is part of why it attracted research interest. You may also see it referred to as Body Protection Compound 157, PL 14736, or bepecin. It is a research compound and is not approved by the FDA or other regulators for human use.
How BPC-157 is studied to work
Across animal studies, researchers have proposed several overlapping mechanisms rather than a single mode of action. The most consistently reported is an effect on angiogenesis — the formation of new blood vessels — which supports tissue repair by improving blood supply to an injured area.
- VEGFR2 activation: BPC-157 is reported to up-regulate and activate the VEGFR2 receptor, a central switch in blood-vessel growth.
- Nitric-oxide pathway: downstream signaling through the Src–Caveolin-1–eNOS pathway is described, increasing nitric-oxide availability and influencing vascular tone.
- Growth-factor and Egr-1 signaling: studies also point to interactions with growth-factor pathways and early growth response factor-1, which help coordinate cell migration and repair.
A 2025 narrative review in Current Reviews in Musculoskeletal Medicine organized three decades of work around four mechanistic pillars: VEGFR2-mediated angiogenesis, eNOS coupling, ERK1/2 signaling, and anti-inflammatory modulation. Importantly, almost all of this evidence comes from cell and rodent models.
Reported effects and benefits in the research literature
In published animal research, the effects most often associated with BPC-157 cluster around connective-tissue repair and protection of the gut. These are the outcomes that have driven interest in the peptide:
- Tendon and ligament models: faster healing, tendon-cell outgrowth, and improved cell survival and migration after injury.
- Muscle injury: recovery signaling reported after crush and strain injuries in rodents.
- Gastrointestinal tract: protective effects on the stomach lining and gut in ulcer and inflammatory-bowel models — consistent with its gastric-juice origin.
- Blood vessels and wound healing: pro-angiogenic activity linked to the VEGFR2 / nitric-oxide pathway described above.
What this does not mean: these are preclinical findings. They should not be read as evidence that BPC-157 is safe or effective in people. The enthusiasm often seen online runs well ahead of the controlled human data, which remains very limited.
What the human evidence shows
Well-controlled human trials of BPC-157 are lacking. The bulk of the literature is animal and laboratory work, much of it from a single research group, with a growing but still small set of independent replications. Because of this evidence gap, regulators have taken a cautious stance.
In September 2023, the U.S. FDA placed BPC-157 in its Category 2 list of bulk drug substances for compounding — substances flagged as potentially presenting significant safety risks. The agency cited concerns including possible immunogenicity for certain routes of administration and difficulty characterizing peptide-related impurities, alongside limited safety data. In practice this restricts traditional compounding pharmacies from preparing it.
Handling, storage and reconstitution (research context)
Like most research peptides, BPC-157 is typically supplied as a lyophilized (freeze-dried) powder that is reconstituted with bacteriostatic water before use in the lab.
- Lyophilized powder: store cool and dark; long-term storage is usually at −20°C.
- After reconstitution: refrigerate at 2–8°C and use within a few weeks.
- Measurement: work in concentration (mg/mL) and volume rather than “units.” Our reconstitution calculator turns vial mg + water volume into concentration and draw volume, and the explainer IU vs mL: why “units” are not a dose clears up the most common measurement mistake.
Cautions and considerations
- BPC-157 is a research compound and is not FDA-approved; it is not a medicine.
- Human safety and efficacy are not established — most evidence is preclinical.
- Purity and identity vary between sources; a Certificate of Analysis (COA) showing purity and identity is essential for any research-grade material.
- This page is informational only and is not medical advice.
Frequently asked questions
Is BPC-157 FDA-approved?
No. BPC-157 is not approved for human use, and in 2023 the FDA placed it on its Category 2 bulk-substances list, citing safety concerns and limited data.
What is BPC-157’s molecular weight and formula?
BPC-157 has the molecular formula C62H98N16O22 and a molecular weight of about 1419.5 g/mol (CAS 137525-51-0).
What is its half-life?
Reported plasma half-life is short — on the order of minutes — though detailed human pharmacokinetic data are limited.
How is BPC-157 stored?
As a lyophilized powder it is kept cool and dark (long-term −20°C); once reconstituted it is refrigerated at 2–8°C and used within a few weeks.
Related compounds and further reading
- Ipamorelin — a selective growth-hormone secretagogue studied in a different research area.
- Browse the full peptide library for more compound profiles.
- Storage, stability and handling guides for research peptides.
- IU vs mL: why “units” are not a dose — the measurement basics behind every calculation.
- How to reconstitute peptides — step-by-step reconstitution method and concentration math.
- Sterile technique — aseptic handling and contamination prevention for research vials.